Neurogene Stock Analysis

Neurogene Stock Analysis Notes

About 89.0% of the company shares are owned by institutional investors. The book value of Neurogene was now reported as 11.93. The company recorded a loss per share of 3.66. Neurogene had not issued any dividends in recent years. The entity had 1:4 split on the 19th of December 2023. To find out more about Neurogene contact the company at (855) 508-3568 or learn more at https://www.neurogene.com.

Neurogene Investment Alerts

Neurogene Upcoming and Recent Events

Neurogene Largest EPS Surprises

View All Earnings Estimates

Neurogene Environmental, Social, and Governance (ESG) Scores

Neurogene Market Capitalization

The company currently falls under 'Small-Cap' category with a current market capitalization of 593.14 M.

Neurogene Profitablity

Management Efficiency

Neurogene has return on total asset (ROA) of (0.3236) % which means that it has lost $0.3236 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.4134) %, meaning that it created substantial loss on money invested by shareholders. Neurogene's management efficiency ratios could be used to measure how well Neurogene manages its routine affairs as well as how well it operates its assets and liabilities. As of December 4, 2024, Return On Tangible Assets is expected to decline to -0.17. In addition to that, Return On Capital Employed is expected to decline to -0.29. The current year's Debt To Assets is expected to grow to 0, whereas Total Assets are forecasted to decline to about 155.8 M.

Technical Drivers

As of the 4th of December, Neurogene secures the Mean Deviation of 6.31, risk adjusted performance of 0.0056, and Standard Deviation of 11.45. In connection with fundamental indicators, the technical analysis model lets you check existing technical drivers of Neurogene, as well as the relationship between them. Please verify Neurogene market risk adjusted performance, variance, as well as the relationship between the Variance and value at risk to decide if Neurogene is priced some-what accurately, providing market reflects its recent price of 22.02 per share. Given that Neurogene has information ratio of (0.01), we recommend you to check Neurogene's last-minute market performance to make sure the company can sustain itself at a future point.

Neurogene Price Movement Analysis

Neurogene Insider Trading Activities

Neurogene Predictive Daily Indicators

Neurogene Corporate Filings

Neurogene Forecast Models

Neurogene's time-series forecasting models are one of many Neurogene's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Neurogene's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how Neurogene prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Neurogene shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Neurogene. By using and applying Neurogene Stock analysis, traders can create a robust methodology for identifying Neurogene entry and exit points for their positions.

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Neurogene analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Neurogene analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.

Neurogene stock analysis indicators help investors evaluate how Neurogene stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Neurogene shares will generate the highest return on investment. By understating and applying Neurogene stock analysis, traders can identify Neurogene position entry and exit signals to maximize returns.

When running Neurogene's price analysis, check to measure Neurogene's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Neurogene is operating at the current time. Most of Neurogene's value examination focuses on studying past and present price action to predict the probability of Neurogene's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Neurogene's price. Additionally, you may evaluate how the addition of Neurogene to your portfolios can decrease your overall portfolio volatility.